WHAT: A free public presentation and question/answer session on innovations in the treatment of advanced prostate cancer.
WHEN: 5:30 to 7 p.m. Thursday, July 9, 2015
WHERE: Cancer Therapy & Research Center, 7979 Wurzbach Road, 4th Floor Grossman Building, San Antonio
WHO: Ian M. Thompson, Jr., M.D., CTRC director, and Devalingam Mahalingam, M.D., Ph.D., CTRC oncologist
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.